SlideShare a Scribd company logo
CANCER FATIGUE
DR.BAGHATH SINGH
SECOND YEAR RESIDENT
GENERAL MEDICINE
GRH MADURAI
FATIGUE
• Multifaceted condition characterized by
• DIMINISHED ENERGY
• INCREASED NEED TO REST DISPROPORTIONATE TO ACTIVITY
• GENERALISED WEAKNESS
• DIMINISHED MENTAL CONCENTRATION
• SLEEP DISTURBANCES
• EMOTIONAL REACTIVITY
PREVALENCE
• 25 to 99 percent of cancer patients
• Higher proportion of patients suffer compared to normal population
• CRF leads to poor physical ,social, cognitive and vocational functioning.
• Leads to emotional and spiritual distress in both patient and family members.
DEFINITION
• Distressing persistent subjective sense of
Physical ,emotional and or cognitive tiredness . exhaustion related to cancer
Or cancer treatment ,that is not proportional to recent activity and that
interferes with usual functioning.
RISK FACTORS FOR FATIGUE
• Chemotherapy
• Hormone therapy
• Radiation therapy
• Immunotherapy
• Cumulative fatigue peaks in fractional radiation therapy
MECHANISMS
• Genetic polymorphisms
• HPA disruption
• Altered circadian rhythm
• Immune dysfunction
• Mitochondrial dysfunction
• Excess pro inflammatory cytokines
• Impaired psychological coping mechanisms
• Impaired neuro endocrine stress responses
ASSOCIATED FACTORS
• Anemia
• Hypothyroidism
• Hypogonadism
• Hepatic dysfunction
• Renal failure
• Infection
• Electrolyte disturbances
• Malnutrition
• Dehydration
• Drug induced
SCREENING AND EVALUATION
National comprehensive cancer network GUIDELINES
• Fatigue should be recognized, evaluated, monitored, documented, and treated
promptly for all age groups, at all stages of disease,
• prior to, during, and following treatment.
BARRIERS TO COMMUNICATION IN CRF
• Patient and physicians view that fatigue is inevitable in the disease
• Patients desire to go about without medications
• Patients wish to be a non complainer
• Patients fear of being treated with a modified less effective therapy
DIMENSIONS OF FATIGUE
• Sensory dimension
• Physiologic dimension
• Performance dimension
• Single screeningtool is inadequate to encompass all the dimensions
• More than 20 different self reporting measures have been developed to measure
fatigue in cancer patients
INTERVENTIONS
• General supportive measures
• Balanced diet
• Balanced rest and physical activities
• Exposure to natural environment
• Pleasant distraction like music
PHARMACOLOGICAL
INTERVENTION
• Use of EPO analogues in severe anemia management.
• Paroxetine ,bupropion and venlafaxine .
• Paroxetine 10mg od increased 10mg per week to max 40mg per day.
• BUPROPION 100mg BD to 100 mg q8h
• Venlafaxine 37.5 mg BD
PSYCHOSTIMULANTS
Drugs like methylphenidate and modafanil
• Steroids
• Megestrol acetate
• Ginseng
• Harmone supplements not beneficial.
• May be counter productive
• Vitamin supplements, zinc ,omega 3 fatty acid supplements inconclusive evidence.
EXERCISE PHYSICAL ACTIVITY AND STRUCTURED
REHABILITATION
• Depending upon the status of the patient individualised exercise program to be
instituted.
• Patients should aim for 150 minutes of moderate intensity physical activity and
strength training twice a week.
• Yoga ,tai chi, organised sports also could be incorporated
PSYCHO EDUCATIONAL
INTERVENTIONS
• Cognitive behavioural therapy ,hypnosis
• Psychological support
• Coaching to enhance self efficiency
• Energy conservation and activity management.
INTERVENTIONS TO IMPROVE SLEEP
QUALITY AND CIRCADIAN RHYTHMICITY
• Cognitive behavioural therapy
• Sleep hygiene
• Relaxation training
• Avoiding stimulants at bed time
• Morning bright light exposure
• Strategies to reduce Cognitive arousal
COMPLEMENTARY THERAPIES
THANK YOU

More Related Content

What's hot

Chemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical StudentsChemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical Students
Prof. Shad Salim Akhtar
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
CHSSscience
 
Cancer chemotherapy part I
Cancer chemotherapy part ICancer chemotherapy part I
Cancer chemotherapy part I
Mahatma Gandhi Medical College & Hospital
 
Toxicities of targeted therapies
Toxicities of targeted therapiesToxicities of targeted therapies
Toxicities of targeted therapiesRasha Haggag
 
CHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERSCHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERS
Yashveer Singh
 
Chemotherapy in head and neck
Chemotherapy in head and neck Chemotherapy in head and neck
Chemotherapy in head and neck
SREENIVAS KAMATH
 
Pharmacogenomics mine
Pharmacogenomics minePharmacogenomics mine
Pharmacogenomics mine
LAKSHMI DEEPTHI GEDELA
 
Antiemetics 07122017
Antiemetics 07122017Antiemetics 07122017
Antiemetics 07122017
Varshu Goel
 
Targeted therapy in breast cancer
Targeted therapy in breast cancerTargeted therapy in breast cancer
Targeted therapy in breast cancer
dr-kannan
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
Hoda Azmy
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapyRasha Haggag
 
Chemotherapy
Chemotherapy Chemotherapy
Chemotherapy
Niti Sarawgi
 
Treatment of breast cancer
Treatment of breast cancerTreatment of breast cancer
Treatment of breast cancer
jeevan kishore
 
Cancer and Chemotherapy
Cancer and ChemotherapyCancer and Chemotherapy
Cancer and Chemotherapy
Diana Rangaves, PharmD, CEO
 
Chapter 24 tyrosine kinase inhibitors
Chapter 24 tyrosine kinase inhibitorsChapter 24 tyrosine kinase inhibitors
Chapter 24 tyrosine kinase inhibitors
Nilesh Kucha
 
Management of adverse effects of cancer chemotherapy 1
Management of adverse effects of cancer chemotherapy  1Management of adverse effects of cancer chemotherapy  1
Management of adverse effects of cancer chemotherapy 1
Dr. Pooja
 
Chemotherapy in orthopaedics
Chemotherapy in orthopaedicsChemotherapy in orthopaedics
Chemotherapy in orthopaedicsSudheer Kumar
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapyRa Bia
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
Nilesh Kucha
 

What's hot (20)

Chemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical StudentsChemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical Students
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Cancer chemotherapy part I
Cancer chemotherapy part ICancer chemotherapy part I
Cancer chemotherapy part I
 
Toxicities of targeted therapies
Toxicities of targeted therapiesToxicities of targeted therapies
Toxicities of targeted therapies
 
CHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERSCHEMOTHERAPY IN CANCERS
CHEMOTHERAPY IN CANCERS
 
Chemotherapy in head and neck
Chemotherapy in head and neck Chemotherapy in head and neck
Chemotherapy in head and neck
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugs
 
Pharmacogenomics mine
Pharmacogenomics minePharmacogenomics mine
Pharmacogenomics mine
 
Antiemetics 07122017
Antiemetics 07122017Antiemetics 07122017
Antiemetics 07122017
 
Targeted therapy in breast cancer
Targeted therapy in breast cancerTargeted therapy in breast cancer
Targeted therapy in breast cancer
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
Chemotherapy
Chemotherapy Chemotherapy
Chemotherapy
 
Treatment of breast cancer
Treatment of breast cancerTreatment of breast cancer
Treatment of breast cancer
 
Cancer and Chemotherapy
Cancer and ChemotherapyCancer and Chemotherapy
Cancer and Chemotherapy
 
Chapter 24 tyrosine kinase inhibitors
Chapter 24 tyrosine kinase inhibitorsChapter 24 tyrosine kinase inhibitors
Chapter 24 tyrosine kinase inhibitors
 
Management of adverse effects of cancer chemotherapy 1
Management of adverse effects of cancer chemotherapy  1Management of adverse effects of cancer chemotherapy  1
Management of adverse effects of cancer chemotherapy 1
 
Chemotherapy in orthopaedics
Chemotherapy in orthopaedicsChemotherapy in orthopaedics
Chemotherapy in orthopaedics
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
 

Similar to Cancer related fatigue devitta presentation

Pharmacotherapy and drug devlopement.pptx
Pharmacotherapy and drug devlopement.pptxPharmacotherapy and drug devlopement.pptx
Pharmacotherapy and drug devlopement.pptx
Imtiyaz60
 
Pharmacotherapy and drug devlopement.pdf
Pharmacotherapy and drug devlopement.pdfPharmacotherapy and drug devlopement.pdf
Pharmacotherapy and drug devlopement.pdf
Imtiyaz60
 
Obesity dr njeru
Obesity dr njeruObesity dr njeru
Obesity dr njeru
Ahmedaedy
 
Benzodiazepines in elderly
Benzodiazepines in elderlyBenzodiazepines in elderly
Benzodiazepines in elderlyRavi Soni
 
Treatment Resistant Schizophrenia
Treatment Resistant SchizophreniaTreatment Resistant Schizophrenia
Treatment Resistant Schizophrenia
Subodh Sharma
 
Personalised Medicine- Future of Medicine.
Personalised Medicine- Future of Medicine.Personalised Medicine- Future of Medicine.
Personalised Medicine- Future of Medicine.
Ramya Mishra
 
Therapeutic Index of drugs and Factors modifying drug action
Therapeutic Index of drugs and Factors modifying drug action Therapeutic Index of drugs and Factors modifying drug action
Therapeutic Index of drugs and Factors modifying drug action
Rahul Kunkulol
 
Special topic genomics and personalized medicine
Special topic genomics and personalized medicineSpecial topic genomics and personalized medicine
Special topic genomics and personalized medicine
watsonma12
 
Medication use in elderly
Medication use in elderlyMedication use in elderly
Medication use in elderly
Doha Rasheedy
 
Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
Irene Daniel
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
pramsat
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
kaipu nagi reddy
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
Swati Arora
 
2016: Depression-Nasar
2016: Depression-Nasar2016: Depression-Nasar
2016: Depression-Nasar
SDGWEP
 
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug DevelopementAspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
AnshuNautiyal1
 
Reporting and monitoring adverse events with cancer treatment [final]
Reporting and monitoring adverse events with cancer treatment [final]Reporting and monitoring adverse events with cancer treatment [final]
Reporting and monitoring adverse events with cancer treatment [final]Rosalynn Pangan
 
Adverse Drug Reaction of Chemotherapy.pptx
Adverse Drug Reaction of Chemotherapy.pptxAdverse Drug Reaction of Chemotherapy.pptx
Adverse Drug Reaction of Chemotherapy.pptx
IbrahimHamis2
 
Therapeutic drug monitoring (TDM)
Therapeutic drug monitoring (TDM)Therapeutic drug monitoring (TDM)
Therapeutic drug monitoring (TDM)
Dipesh Tamrakar
 
Recent Advances in Obesity Pharmacotherapy
Recent Advances in Obesity PharmacotherapyRecent Advances in Obesity Pharmacotherapy
Recent Advances in Obesity Pharmacotherapy
Shreya Gupta
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
Teena Patra
 

Similar to Cancer related fatigue devitta presentation (20)

Pharmacotherapy and drug devlopement.pptx
Pharmacotherapy and drug devlopement.pptxPharmacotherapy and drug devlopement.pptx
Pharmacotherapy and drug devlopement.pptx
 
Pharmacotherapy and drug devlopement.pdf
Pharmacotherapy and drug devlopement.pdfPharmacotherapy and drug devlopement.pdf
Pharmacotherapy and drug devlopement.pdf
 
Obesity dr njeru
Obesity dr njeruObesity dr njeru
Obesity dr njeru
 
Benzodiazepines in elderly
Benzodiazepines in elderlyBenzodiazepines in elderly
Benzodiazepines in elderly
 
Treatment Resistant Schizophrenia
Treatment Resistant SchizophreniaTreatment Resistant Schizophrenia
Treatment Resistant Schizophrenia
 
Personalised Medicine- Future of Medicine.
Personalised Medicine- Future of Medicine.Personalised Medicine- Future of Medicine.
Personalised Medicine- Future of Medicine.
 
Therapeutic Index of drugs and Factors modifying drug action
Therapeutic Index of drugs and Factors modifying drug action Therapeutic Index of drugs and Factors modifying drug action
Therapeutic Index of drugs and Factors modifying drug action
 
Special topic genomics and personalized medicine
Special topic genomics and personalized medicineSpecial topic genomics and personalized medicine
Special topic genomics and personalized medicine
 
Medication use in elderly
Medication use in elderlyMedication use in elderly
Medication use in elderly
 
Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
 
2016: Depression-Nasar
2016: Depression-Nasar2016: Depression-Nasar
2016: Depression-Nasar
 
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug DevelopementAspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Developement
 
Reporting and monitoring adverse events with cancer treatment [final]
Reporting and monitoring adverse events with cancer treatment [final]Reporting and monitoring adverse events with cancer treatment [final]
Reporting and monitoring adverse events with cancer treatment [final]
 
Adverse Drug Reaction of Chemotherapy.pptx
Adverse Drug Reaction of Chemotherapy.pptxAdverse Drug Reaction of Chemotherapy.pptx
Adverse Drug Reaction of Chemotherapy.pptx
 
Therapeutic drug monitoring (TDM)
Therapeutic drug monitoring (TDM)Therapeutic drug monitoring (TDM)
Therapeutic drug monitoring (TDM)
 
Recent Advances in Obesity Pharmacotherapy
Recent Advances in Obesity PharmacotherapyRecent Advances in Obesity Pharmacotherapy
Recent Advances in Obesity Pharmacotherapy
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 

Recently uploaded

A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Reflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdfReflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdf
amberjdewit93
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
amberjdewit93
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 

Recently uploaded (20)

A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Reflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdfReflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 

Cancer related fatigue devitta presentation

  • 1. CANCER FATIGUE DR.BAGHATH SINGH SECOND YEAR RESIDENT GENERAL MEDICINE GRH MADURAI
  • 2. FATIGUE • Multifaceted condition characterized by • DIMINISHED ENERGY • INCREASED NEED TO REST DISPROPORTIONATE TO ACTIVITY • GENERALISED WEAKNESS • DIMINISHED MENTAL CONCENTRATION • SLEEP DISTURBANCES • EMOTIONAL REACTIVITY
  • 3. PREVALENCE • 25 to 99 percent of cancer patients • Higher proportion of patients suffer compared to normal population • CRF leads to poor physical ,social, cognitive and vocational functioning. • Leads to emotional and spiritual distress in both patient and family members.
  • 4. DEFINITION • Distressing persistent subjective sense of Physical ,emotional and or cognitive tiredness . exhaustion related to cancer Or cancer treatment ,that is not proportional to recent activity and that interferes with usual functioning.
  • 5. RISK FACTORS FOR FATIGUE • Chemotherapy • Hormone therapy • Radiation therapy • Immunotherapy • Cumulative fatigue peaks in fractional radiation therapy
  • 6. MECHANISMS • Genetic polymorphisms • HPA disruption • Altered circadian rhythm • Immune dysfunction • Mitochondrial dysfunction • Excess pro inflammatory cytokines • Impaired psychological coping mechanisms • Impaired neuro endocrine stress responses
  • 7.
  • 8. ASSOCIATED FACTORS • Anemia • Hypothyroidism • Hypogonadism • Hepatic dysfunction • Renal failure • Infection • Electrolyte disturbances • Malnutrition • Dehydration • Drug induced
  • 9. SCREENING AND EVALUATION National comprehensive cancer network GUIDELINES • Fatigue should be recognized, evaluated, monitored, documented, and treated promptly for all age groups, at all stages of disease, • prior to, during, and following treatment.
  • 10.
  • 11.
  • 12. BARRIERS TO COMMUNICATION IN CRF • Patient and physicians view that fatigue is inevitable in the disease • Patients desire to go about without medications • Patients wish to be a non complainer • Patients fear of being treated with a modified less effective therapy
  • 13.
  • 14.
  • 15.
  • 16. DIMENSIONS OF FATIGUE • Sensory dimension • Physiologic dimension • Performance dimension • Single screeningtool is inadequate to encompass all the dimensions • More than 20 different self reporting measures have been developed to measure fatigue in cancer patients
  • 17. INTERVENTIONS • General supportive measures • Balanced diet • Balanced rest and physical activities • Exposure to natural environment • Pleasant distraction like music
  • 18.
  • 19. PHARMACOLOGICAL INTERVENTION • Use of EPO analogues in severe anemia management. • Paroxetine ,bupropion and venlafaxine . • Paroxetine 10mg od increased 10mg per week to max 40mg per day. • BUPROPION 100mg BD to 100 mg q8h • Venlafaxine 37.5 mg BD
  • 21. • Steroids • Megestrol acetate • Ginseng • Harmone supplements not beneficial. • May be counter productive • Vitamin supplements, zinc ,omega 3 fatty acid supplements inconclusive evidence.
  • 22. EXERCISE PHYSICAL ACTIVITY AND STRUCTURED REHABILITATION • Depending upon the status of the patient individualised exercise program to be instituted. • Patients should aim for 150 minutes of moderate intensity physical activity and strength training twice a week. • Yoga ,tai chi, organised sports also could be incorporated
  • 23. PSYCHO EDUCATIONAL INTERVENTIONS • Cognitive behavioural therapy ,hypnosis • Psychological support • Coaching to enhance self efficiency • Energy conservation and activity management.
  • 24. INTERVENTIONS TO IMPROVE SLEEP QUALITY AND CIRCADIAN RHYTHMICITY • Cognitive behavioural therapy • Sleep hygiene • Relaxation training • Avoiding stimulants at bed time • Morning bright light exposure • Strategies to reduce Cognitive arousal
  • 26.
  • 27.